Long-term L-Triiodothyronine (T3) treatment in stable systolic heart failure patients: a randomised, double-blind, cross-over, placebo-controlled intervention study
about
Long-term L-Triiodothyronine (T3) treatment in stable systolic heart failure patients: a randomised, double-blind, cross-over, placebo-controlled intervention study
description
scientific article published on 17 December 2014
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2014
@uk
name
Long-term L-Triiodothyronine ( ...... -controlled intervention study
@en
Long-term L-Triiodothyronine ( ...... -controlled intervention study
@nl
type
label
Long-term L-Triiodothyronine ( ...... -controlled intervention study
@en
Long-term L-Triiodothyronine ( ...... -controlled intervention study
@nl
prefLabel
Long-term L-Triiodothyronine ( ...... -controlled intervention study
@en
Long-term L-Triiodothyronine ( ...... -controlled intervention study
@nl
P2093
P50
P356
P1476
Long-term L-Triiodothyronine ( ...... -controlled intervention study
@en
P2093
Ilan Raymond
Jens Faber
Pernille Holmager
Peter Mark
Ulla Schmidt
Ulrik Andersen
P304
P356
10.1111/CEN.12648
P577
2014-12-17T00:00:00Z